secwatch.observer — SEC 8-K summary
======================================

Issuer:     VITASPRING BIOMEDICAL CO. LTD. (—)
CIK:        0001697884
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001683168-25-006448
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

VitaSpring Biomedical appoints JP Centurion as new independent auditor
----------------------------------------------------------------------

- Engaged JP Centurion & Partners PLT as independent registered public accounting firm effective August 19, 2025.
- No consultations with JP Centurion on accounting principles or audit opinion prior to engagement.
- No disagreements or reportable events occurred with former auditor (resignation disclosed in prior 8-K on Aug 7, 2025).
- New auditor will audit consolidated financial statements and perform review procedures for periodic reports.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697884/000168316825006448/0001683168-25-006448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697884/000168316825006448/vitaspring_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-006448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer